In order to overcome this barrier, the tumor cells are able to produce fibroblast growth factor 2 (FGF2), which increases the susceptibility of CAFs to infection with OVs, promoting better targeting of CAFs and disruption of the ECM. This evidence concerns the gene FGF2 and infection.